What Leads to Desquamative Inflammatory Vaginitis?
Desquamative inflammatory vaginitis (DIV) is triggered by disruptions in vaginal homeostasis, with the most common precipitating factors being antibiotic use, diarrhea, and other gastrointestinal disturbances, though the exact etiology remains incompletely understood.
Primary Precipitating Factors
The strongest evidence indicates that DIV occurs when specific triggers cause shifts in vaginal homeostasis, resulting in an inflammatory response with increased epithelial cell turnover 1. In a retrospective audit of 101 DIV cases, 56% had identifiable historical triggers 1:
- Antibiotic use (most common)
- Diarrhea or gastrointestinal illness
- Ongoing gastrointestinal conditions requiring treatment
This is significantly different from other vaginal conditions—only 15% of women with vaginal lichen planus had similar triggers (p <0.0001), suggesting DIV has a distinct pathophysiology 1.
Infectious Triggers
While DIV is not primarily an infectious disease, certain pathogens can precipitate the condition:
TSST-1-producing Staphylococcus aureus: Two case reports demonstrate that DIV may be triggered through toxic shock syndrome toxin-1-mediated vaginal toxic shock reaction 2. Both acute and chronic presentations resolved after oral antibiotic therapy targeting S. aureus.
Group B Streptococcus: In the 101-case series, 20% of patients had pure growth of commensal organisms on culture, with 13 being group B streptococci 1.
Anatomical and Hormonal Factors
Cervical ectropion (presence of glandular columnar cells on the ectocervix) has been reported as a potential cause of DIV 3. A case report documented complete resolution of 4-year DIV symptoms after cryotherapy of cervical ectropion, suggesting this anatomical variant can precipitate the condition.
Hormone use is strongly associated with DIV 4:
- Oral contraceptive use (OR = 4.91,95% CI 2.11-11.43)
- Hormone replacement therapy (OR = 4.74,95% CI 2.69-8.37)
Systemic Conditions
Vitamin D deficiency, particularly in the context of Crohn disease, has been associated with DIV 5. Four case reports showed DIV symptoms resolved when circulating 25-hydroxyvitamin D concentrations returned to normal, suggesting altered vaginal mucous membrane function related to vitamin D status.
Risk Factor Profile
A case-control study identified additional associations 4:
- History of vulvovaginal candidiasis (OR = 4.40)
- History of bacterial vaginosis (OR = 25.58)
- History of pelvic inflammatory disease (OR = 16.90)
- Laparoscopic procedures (OR = 22.24)
Clinical Pitfalls
Critical caveat: 54% of DIV patients had no significant abnormality on laboratory microbiological testing 1. This means standard vaginal cultures and microscopy are often unrevealing, leading to misdiagnosis as candidiasis or bacterial vaginosis with repeated ineffective treatments 3.
Important distinction: DIV and plasma cell vulvitis may represent a spectrum of the same condition (hemorrhagic vestibulovaginitis) with varying manifestations according to location and severity 6, so consider both diagnoses when evaluating inflammatory vaginitis.
Pathophysiologic Mechanism
The current understanding suggests DIV develops through this pathway:
- A trigger (antibiotics, GI illness, hormonal changes, anatomical factors) disrupts normal vaginal flora
- This disruption causes shifts in vaginal homeostasis
- An inflammatory response ensues with increased epithelial cell turnover
- In susceptible individuals, this becomes a chronic inflammatory state requiring maintenance therapy (35% of cases) 1
When triggers are ongoing (like untreated Crohn disease or persistent cervical ectropion), DIV persists until the underlying trigger is controlled 1.